Lateral Flow Assay Components Market to Hit USD 486.2 Million by 2030: Rising Prevalence of Infectious Diseases Drives Growth [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
million in 2025, with a CAGR of 4.4%. This expansion is driven by rising infectious diseases, demand for point-of-care testing, and home-based diagnostics. Sandwich assays dominate due to their high sensitivity and specificity in clinical settings. Medical device manufacturers lead market demand, while contract manufacturers grow, especially in Asia-Pacific. Rapid healthcare expansion and favorable economics make Asia-Pacific the fastest-growing region. Top players include Danaher Corp., Merck KGaA, and Ahlstrom. Lateral Flow Assay Components Market Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Components Market by Type, Application, Technique, End User, and Region - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The global lateral flow assay (LFA) components market is anticipated to expand from USD 392.4 million in 2025 to USD 486.2 million by 2030, achieving a CAGR of 4.4% over this period. This growth is fueled by the rising
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Should Goldman's Bioprocessing Call and Dividend Steadiness Require Action From Danaher (DHR) Investors? [Yahoo! Finance]Yahoo! Finance
- Danaher (NYSE:DHR) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.MarketBeat
- Danaher: Biotech Strength And Cash Generation Reinforce A $250 Fair Value [Seeking Alpha]Seeking Alpha
- Danaher Announces Quarterly Dividend [Yahoo! Finance]Yahoo! Finance
- Danaher declares $0.32 dividend [Seeking Alpha]Seeking Alpha
DHR
Earnings
- 10/21/25 - Beat
DHR
Sec Filings
- 11/26/25 - Form 4
- 11/25/25 - Form 144
- 11/25/25 - Form 144
- DHR's page on the SEC website